ANKRD26P2

Across TCGA pan-cancer cohorts, ANKRD26P2 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ANKRD26P2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ANKRD26P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ANKRD26P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and STAD show a favorable association.

ACC, READ, and LGG are the cancer types where ANKRD26P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.182	0.678	.004	57	view →
READ	DFS	Tertile	II,III,IV	0.400	0.809	.007	54	view →
LGG	DFS	Tertile	All	0.247	0.449	<.001	33	view →
CESC	DFS	Tertile	IV	0.053	0.529	<.001	24	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
LUAD	DFS	Tertile	All	0.675	0.823	.010	12	view →
SKCM	OS	Tertile	All	0.863	0.357	.031	9	view →
STAD	OS	Median	IV	0.564	0.192	.004	9	view →
SARC	OS	Tertile	All	0.322	0.521	.032	6	view →
KIRP	DFS	Tertile	All	1.000	0.844	.049	3	view →
LUSC	OS	Tertile	II,III,IV	0.917	0.727	.037	3	view →
KIRC	DFS	Tertile	All	0.775	0.570	.033	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

ANKRD26P2–ACC (DFS)

Open the ACC breakdown →